Document is current
Any future updates will be listed below
-
Authors
Joseph, Michele http://orcid.org/0000-0002-2336-710X
Woldeamanuel, Yimtubeznash
Medhin, Girmay
Manyazewal, Tsegahun
Fekadu, Abebaw
Makonnen, Eyasu
-
Funding
Funding for this research was provided by:
Vins Bioproducts Limited
- License Information
-
More Information
Article History
Received: 26 December 2022
Accepted: 30 April 2023
First Online: 5 May 2023
Declarations
:
: The study was reviewed and approved by: (I) the Institutional Review Board of the College of Health Sciences, Addis Ababa University (protocol No 071/19/CDT) dated 30 December 2020, and (II) the Ethical Clearance Committee of the Addis Ababa Health City Administration Health Bureau (Ref No.: A/A/0570/227) dated 26 March 2021. The Health bureau and the study sites have permitted data collection. All the information retrieved from charts reviews and information about study sites were identified by code numbers. All records were kept locked at the CDT-Africa office. All computers used for the study were locked with a password.
: Not applicable.
: The investigators, individually and collectively, declare that they had no conflict of interest with the Sponsor. As participants to the TAT-Safe study, the Investigators, through their designated Institution, and the Sponsor have signed a formal agreement to conduct the study in accordance with the statements and procedures stipulated in the study protocol.
